HB 2122: Cannabinoid products

Concerning cannabinoid products.

1. IntroducedFeb 21, 2022
2. Out of committeestopped here
3. Passed House
4. Passed Senate
5. Governor
6. Law

Prime sponsor

Shelley Kloba (D-1)

Introduced

February 21, 2022 in the House

Last action

February 21, 2022

Budget

Has a fiscal note

AN ACT Relating to protecting consumers from untested and unregulated cannabinoid products by expanding agency regulatory authority over cannabinoids that may be impairing, modifying definitions in the uniform controlled substances act, prohibiting the sale of certain cannabinoid products except by licensed cannabis businesses, regulating the use of additives in cannabis products, requiring product testing and disclosures, prohibiting the manufacture and sale of artificial cannabinoids, requiring agency rules before the manufacture and sale of synthetically derived cannabinoids, prohibiting artificial cannabinoids and synthetically derived cannabinoids in products labeled as compliant with department of health product standards and available for an existing sales and use tax exemption, and establishing a temporary license fee surcharge on certain licensees of the liquor and cannabis board to fund enforcement related to sales of cannabinoid products that may be impairing or are marketed as impairing;